A Community Built for Survivors and Clinicians Alike
The OncoMenopause Consortium is a dedicated education initiative of HERmedicine, a national 501(c)(3) nonprofit committed to advancing evidence-based women’s health. The Consortium is governed by the HERmedicine Board of Directors and guided by the OncoMenopause Education Committee, which provides clinical leadership and direction for its educational programming.
Menopause care is complex. After cancer, it becomes even more nuanced.
Survivors deserve informed, coordinated, and compassionate care—and clinicians need practical tools, trusted guidance, and a collaborative community to deliver it.
Cancer survivorship and menopause share important parallels. Both demand individualized, evidence-based approaches that account for long-term health, quality of life, and evolving needs. Yet care in both areas too often remains fragmented, leaving survivors and clinicians without the integrated resources necessary for confident decision-making.
The OncoMenopause Consortium was created to bridge this gap.
We bring together multidisciplinary clinicians across oncology, gynecology, internal medicine, endocrinology, nursing, pharmacy, psychology, and sexual health—alongside survivHERs whose lived experience informs and strengthens our work. Through shared learning, dialogue, and collaboration, we foster education and connection that reflect both clinical expertise and survivor voice.
By uniting disciplines and centering evidence-based practice and lived experience, the OncoMenopause Consortium is working to redefine survivorship and midlife health—so individuals receive comprehensive, coordinated care in the years beyond cancer.
Our Mission
To empower and support individuals navigating menopause after cancer and the clinicians who care for them by providing evidence-based education, clinical resources, and community connections that improve quality of life and foster informed, collaborative conversations between survivors and clinicians.
Our Vision
We envision a world where every person affected by cancer can experience menopause with confidence, compassion, and access to the best care and information available—bridging the gap between oncology and women’s health.
Our Founder
The OncoMenopause Consortium, founded by Lisa Larkin, MD, is a specific education initiative of HERmedicine, a 501(c)(3) nonprofit dedicated to advancing evidence-based women’s health.
Established to address the unique intersection of menopause and cancer survivorship, the Consortium strengthens multidisciplinary collaboration, advances clinical education, and supports the development of evidence-informed resources for individuals navigating menopause after cancer.
Lisa Larkin, MD, FACP, MSCP, IF
Lisa Larkin, MD, FACP, MSCP, IF, is a leader in internal medicine and women’s health with more than three decades of clinical experience and the unique perspective of being a breast cancer survivor. She is the founder of HERmedicine, a national 501(c)(3) nonprofit advancing evidence-based women’s health, and the founder and president of Ms.Medicine.
A Fellow of the American College of Physicians, a Certified Menopause Practitioner, and a Fellow of ISSWSH, Dr. Larkin maintains an active concierge internal medicine and women’s health practice focused on evidence-based care and long-term patient relationships.
She provides executive women’s health consultations and telemedicine services across multiple states, with expertise in menopause, sexual health, and preventive medicine. Dr. Larkin is recognized nationally for her leadership, innovation, and commitment to elevating standards of care in women’s health.
OncoMenopause Consortium Education Committee
The OncoMenopause Consortium is guided by the OncoMenopause Education Committee, a group of nationally recognized clinicians whose expertise spans medical oncology, survivorship, supportive care, and women’s health. Together, the committee brings deep experience caring for individuals with breast and gynecologic cancers and plays a central role in shaping the Consortium’s educational priorities, multidisciplinary programming, and clinician engagement efforts.
Maryam Lustberg, MD, MPH
Maryam Lustberg, MD, MPH, is a breast medical oncologist and serves as Chair of the OncoMenopause Education Committee and a member of the HERmedicine Board of Directors. She is currently Chief of Breast Oncology and Director of the Breast Center at Yale Cancer Center in New Haven, Connecticut.
Dr. Lustberg is the co-chair of Symptom Intervention for the National Cancer Institute Alliance Clinical Trials and the immediate Past President of MASCC, an international organization dedicated to improving cancer supportive care worldwide. Her research focuses on biomarkers of therapeutic response and toxicity, cancer treatment symptom management, and the optimization of survivorship care.
Governance & Leadership
The OncoMenopause Consortium is guided by the HERmedicine Board of Directors, whose oversight ensures our work remains evidence-based, mission-driven, and grounded in clinical integrity. The Board provides strategic leadership across HERmedicine’s initiatives, supporting the OncoMenopause Consortium’s focus on improving menopause and survivorship care through education, collaboration, and community.
Their collective expertise helps ensure that OncoMenopause programming, partnerships, and resources reflect the highest standards of care while advancing a more informed, connected future for cancer survivors and the clinicians who support them.